NEW YORK, Nov. 9, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of
financial markets for 10,000 U.S. and global securities, today announced Lombard Medical, Inc. (OTCQX: EVARF) ("Lombard Medical"),
a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, has qualified to trade on the
OTCQX® Best Market. Lombard Medical previously traded on the Nasdaq Capital Market.
Lombard Medical begins trading today on OTCQX under the symbol "EVARF." U.S. investors can find current financial
disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are pleased to welcome Lombard Medical to the OTCQX market," said Jason Paltrowitz,
Executive Vice President of OTC Markets Group. "Trading on OTCQX will allow Lombard Medical to continue to provide a high-quality
trading and information experience for its investors with less cost and complexity."
About Lombard Medical
Lombard Medical, Inc. based in Oxfordshire, U.K., develops, manufactures and markets
an innovative range of minimally invasive abdominal aortic aneurysm endovascular repair products. For more information, please
visit www.lombardmedical.com
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink®
Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers
that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and
empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
View original content with multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-lombard-medical-to-otcqx-300552926.html
SOURCE OTC Markets Group Inc.